iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Wellington Shields & Co. LLC

Wellington Shields & Co. LLC reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 43.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 900 shares of the financial services provider’s stock after selling 700 shares during the period. Wellington Shields & Co. LLC’s holdings in iShares Biotechnology ETF were worth $119,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the stock. Aptus Capital Advisors LLC raised its holdings in iShares Biotechnology ETF by 36.5% in the 3rd quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock valued at $62,000 after acquiring an additional 114 shares during the last quarter. Huntington National Bank raised its holdings in iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after acquiring an additional 160 shares during the last quarter. OneDigital Investment Advisors LLC raised its holdings in iShares Biotechnology ETF by 32.7% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 10,805 shares of the financial services provider’s stock valued at $1,573,000 after acquiring an additional 2,661 shares during the last quarter. Signature Estate & Investment Advisors LLC raised its holdings in iShares Biotechnology ETF by 8.1% in the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 8,901 shares of the financial services provider’s stock valued at $1,296,000 after acquiring an additional 669 shares during the last quarter. Finally, Evolution Wealth Advisors LLC raised its holdings in iShares Biotechnology ETF by 3.3% in the 3rd quarter. Evolution Wealth Advisors LLC now owns 22,532 shares of the financial services provider’s stock valued at $3,281,000 after acquiring an additional 710 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $134.19 on Friday. The stock has a fifty day moving average of $136.25 and a two-hundred day moving average of $139.81. The company has a market capitalization of $6.34 billion, a PE ratio of 24.52 and a beta of 0.84. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.